Estimation of cost value for health care professionals based on the convenience of anti-influenza agent baloxavir marboxil

Not Applicable

• Conditions: influenza

• Registration Number: JPRN-UMIN000042606
• Lead Sponsor: Shionogi & Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-12-01
• Study Completion: 2020-12-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 2750

Inclusion Criteria

Not provided

Exclusion Criteria

N/A

Study & Design

• Study Type: Others,meta-analysis etc
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ength of time and frequency of drug administration instruction/assistance.

Secondary Outcome Measures

Name	Time	Method
Whether to feel worried about infection or not and willing to pay to avoid infection risk when doing drug administration instruction/assistance.